Safety of immunisation and adverse events following vaccination against hepatitis B

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.2, Iss.3, 2003-05, pp. : 225-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vaccination of blood donors against hepatitis B is feasible, safe and cost–effective

By Gärtner Barbara C

Future Virology, Vol. 6, Iss. 10, 2011-10 ,pp. : 1139-1141

Future Medicine

Access to resources Recommend Favorite

Hepatitis B vaccination may allow discontinuation of hepatitis B immunoglobulin (HBIG) following liver transplantation

Inpharma, Vol. 1, Iss. 1230, 2000-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

A review of hepatitis B vaccination

By Geier Mark R Geier David A Zahalsky Arthur C

Expert Opinion on Drug Safety, Vol. 2, Iss. 2, 2003-03 ,pp. : 113-122

Informa Healthcare

Access to resources Recommend Favorite

Monitoring Adverse Events of the Vaccination Campaign Against Influenza A (H1N1) in the Netherlands

By van Puijenbroek Eugène P. Broos Nancy >

Drug Safety, Vol. 33, Iss. 12, 2010-12 ,pp. : 1097-1108

Adis International

Access to resources Recommend Favorite

Morbidity from hepatitis B reduced after nationwide immunisation

Inpharma, Vol. 1, Iss. 1322, 2002-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite